Eplerenone administration has beneficial effect on hepatic paraoxonase 1 activity in diabetic mice
- 1 January 2010
- journal article
- other
- Published by Elsevier in Atherosclerosis
- Vol. 208 (1) , 26-27
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary densityThe FASEB Journal, 2009
- Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative propertiesFree Radical Biology and Medicine, 2008
- Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat modelLife Sciences, 2008
- α-Lipoic Acid Prevents the Increase in Atherosclerosis Induced by Diabetes in Apolipoprotein E–Deficient Mice Fed High-Fat/Low-Cholesterol DietDiabetes, 2006
- Eplerenone With Valsartan Effectively Reduces Atherosclerotic Lesion by Attenuation of Oxidative Stress and InflammationArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Altered Gene Expression in Liver from a Murine Model of HyperhomocysteinemiaJournal of Biological Chemistry, 2003
- Effect of Eplerenone, a Selective Aldosterone Blocker, on Blood Pressure, Serum and Macrophage Oxidative Stress, and Atherosclerosis in Apolipoprotein E–Deficient MiceJournal of Cardiovascular Pharmacology, 2003
- Paraoxonase and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Glycation impairs high-density lipoprotein functionDiabetologia, 2000
- Anti-Aldosterone Treatment and the Prevention of Myocardial Fibrosis in Primary and Secondary HyperaldosteronismJournal of Molecular and Cellular Cardiology, 1993